ArticleCureus2024
Assessment and Correlation of TP53 With Histological Parameters of Oral Squamous Cell Carcinoma.
Article in Cureus, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background Oral squamous cell carcinoma is a common problem among tobacco chewers and related products in developing countries like India. Histopathological examination evaluates and confirms the diagnosis of oral SCC. Clinical examination and molecular profiling by histopathological examination (HPE) are important prognostic tools used in clinical practice. Histopathological grade, depth of invasion, lymphovascular invasion, perineural invasion and necrosis are the factors routinely assessed in every case during clinical examination. Aim and objectives The present study aims to evaluate TP53 expression and correlate it with the histopathological parameters of oral squamous cell carcinoma. Materials and methods The present retrospective study was conducted in the histopathological section of the Department of Pathology, Atal Bihari Vajpayee Government Medical College, Vidisha, Madhya Pradesh. All the histopathologically diagnosed cases of oral squamous cell carcinoma from November 2023 to October 2024 were included in the study. The collected data were scored, and the immunopositivity of P53 was recorded and correlated with histopathological parameters. Results Oral SCC histopathology was reviewed retrospectively, and the association of histopathological features with P53 was discussed. A total number of 45 cases were included in the study. The most common age group was 41-50 years comprising 18 patients (40%), followed by the 31-40 years age group consisting of 12 patients (26%). According to histopathological parameters, they were graded, scored, and correlated with P53. A p-value <0.05 was considered statistically significant. Conclusion The initiating step in the treatment of patients with precancerous or malignant diseases in the oral cavity is accurate and timely diagnosis. The histopathological examination of suspicious oral lesions is currently the gold standard for diagnosis. The correct interpretation of biopsy, along with clinical and molecular evaluations, improves the prognosis. This study focuses on the importance of reporting various histopathological parameters of oral SCC.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.